ProQuest Investments IV, L.P., 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 198,742 shares at $66.15 ($13.2M) on 2016-09-21, disclosed to the SEC on 2016-09-23.
Open-market sale of $13.2M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.15 | 97,149 | $6.4M | 48.9% |
| 2 | $66.15 | 97,149 | $6.4M | 48.9% |
| 3 | $66.17 | 194 | $13K | 0.1% |
| 4 | $66.17 | 654 | $43K | 0.3% |
| 5 | $67.24 | 1,798 | $121K | 0.9% |
| 6 | $67.24 | 1,798 |
| $121K |
| 0.9% |
| Total | $66.17 avg | 198,742 | $13.2M | 100% |
| Filing → |
| EGRX | SELL | 2016-10-04 | $1.5M | — | Filing → |
| EGRX | SELL | 2016-08-25 | $1.8M | — | Filing → |
| EGRX | SELL | 2016-08-17 | $6.1M | — | Filing → |